• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在 COVID-19 大流行期间吸取的经验教训:对于终末期肾病患者,我们应优先考虑家庭为基础的治疗和远程医疗。

Lessons Learnt during the COVID-19 Pandemic: For Patients with End-Stage Renal Disease, We Should Prioritize Home-Based Treatment and Telemedicine.

机构信息

Division of Nephrology and Dialysis, Santa Chiara Hospital, Trento, Italy,

Department of Medicine, University of Perugia, Perugia, Italy.

出版信息

Kidney Blood Press Res. 2021;46(1):11-16. doi: 10.1159/000512629. Epub 2021 Jan 29.

DOI:10.1159/000512629
PMID:33517338
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7900471/
Abstract

BACKGROUNDS

The recent coronavirus disease 2019 (CO-VID-19) pandemic has placed worldwide health systems and hospitals under pressure, and so are the renal care models. This may be a unique opportunity to promote and expand alternative models of health-care delivery in patients undergoing renal replacement therapies.

SUMMARY

Despite the high risk of acquiring communicable diseases when undergoing in-centre treatments, only a small proportion of patients are currently being treated with home therapies. Recent data provided by the Italian Society of Nephrology (SIN), the REIN French Registry and the Wuhan Hemodialysis Quality Control Center clearly show that patients receiving hospital-based treatment have a 3- to 4-fold greater risk of infection, and a subsequent fatality proportion between 21 and 34%. On the other hand, home-based therapy can be managed remotely, there is little or no need for transport to and from the hospital, and it is less expensive. Besides, the digital revolution in health care with the development of virtual care systems can make home dialysis with telehealth a cost-effective solution for both patients and health-care providers. Such a transition would require specific training for physicians and health-care professionals and a functional re-organization of dialysis centres to improve the skills and expertise in caring for patients at home.

CONCLUSION

The need for more widespread home treatment is the main lesson learnt by nephrologists by the COVID-19 pandemic.

摘要

背景

最近的 2019 年冠状病毒病(COVID-19)大流行给全球卫生系统和医院带来了压力,肾脏护理模式也是如此。这可能是一个独特的机会,可以在接受肾脏替代治疗的患者中推广和扩大替代医疗保健模式。

总结

尽管在接受中心治疗时感染传染病的风险很高,但目前只有一小部分患者正在接受家庭治疗。最近意大利肾脏病学会(SIN)、法国 REIN 登记处和武汉血液透析质量控制中心提供的最新数据清楚地表明,接受医院治疗的患者感染的风险增加了 3 到 4 倍,随后的死亡率在 21%至 34%之间。另一方面,家庭治疗可以远程管理,几乎不需要往返医院,而且成本更低。此外,随着虚拟护理系统的发展,医疗保健领域的数字化革命可以使远程医疗家庭透析成为患者和医疗保健提供者的一种具有成本效益的解决方案。这种转变需要对医生和医疗保健专业人员进行特定的培训,并对透析中心进行功能重组,以提高在家中照顾患者的技能和专业知识。

结论

COVID-19 大流行让肾病学家吸取的主要教训是需要更广泛地开展家庭治疗。

相似文献

1
Lessons Learnt during the COVID-19 Pandemic: For Patients with End-Stage Renal Disease, We Should Prioritize Home-Based Treatment and Telemedicine.在 COVID-19 大流行期间吸取的经验教训:对于终末期肾病患者,我们应优先考虑家庭为基础的治疗和远程医疗。
Kidney Blood Press Res. 2021;46(1):11-16. doi: 10.1159/000512629. Epub 2021 Jan 29.
2
Home Dialysis in the Coronavirus Disease 2019 Era.2019年冠状病毒病时代的家庭透析
Adv Chronic Kidney Dis. 2020 Sep;27(5):442-446. doi: 10.1053/j.ackd.2020.07.001. Epub 2020 Jul 7.
3
Telehealth for Home Dialysis in COVID-19 and Beyond: A Perspective From the American Society of Nephrology COVID-19 Home Dialysis Subcommittee.新冠疫情期间及之后的家庭透析远程医疗:美国肾脏病学会新冠疫情家庭透析小组委员会的观点。
Am J Kidney Dis. 2021 Jan;77(1):142-148. doi: 10.1053/j.ajkd.2020.09.005. Epub 2020 Sep 28.
4
Policy and Pandemic: The Changing Practice of Nephrology During the Coronavirus Disease-2019 Outbreak.政策与大流行:2019 冠状病毒病疫情期间肾脏病学实践的变化。
Adv Chronic Kidney Dis. 2020 Sep;27(5):390-396. doi: 10.1053/j.ackd.2020.06.003. Epub 2020 Jun 24.
5
Cost-effectiveness of home telemonitoring in chronic kidney disease patients at different stages by a pragmatic randomized controlled trial (eNephro): rationale and study design.一项实用随机对照试验(eNephro)评估不同阶段慢性肾病患者家庭远程监测的成本效益:原理与研究设计
BMC Nephrol. 2017 Apr 5;18(1):126. doi: 10.1186/s12882-017-0529-2.
6
Why and how should we promote home dialysis for patients with end-stage kidney disease during and after the coronavirus 2019 disease pandemic? A French perspective.为何以及如何应在 2019 冠状病毒病大流行期间和之后提倡终末期肾病患者进行家庭透析?法国的观点。
J Nephrol. 2021 Aug;34(4):985-989. doi: 10.1007/s40620-021-01061-7. Epub 2021 Jun 1.
7
The use of virtual physician mentoring to enhance home dialysis knowledge and uptake.利用虚拟医师指导来增强居家透析知识和接受度。
Nephrology (Carlton). 2021 Jul;26(7):569-577. doi: 10.1111/nep.13867. Epub 2021 Mar 11.
8
[Remote patient monitoring in dialysis patients: the "change of pace" for home dialysis.].[透析患者的远程患者监测:家庭透析的“节奏变化”。]
Recenti Prog Med. 2020 Jul-Aug;111(7):404-410. doi: 10.1701/3407.33922.
9
Home hemodialysis during the COVID-19 epidemic: comment on the French experience from the viewpoint of a French home hemodialysis care network.新冠疫情期间的家庭血液透析:从法国家庭血液透析护理网络的角度对法国经验的评论
J Nephrol. 2020 Dec;33(6):1125-1127. doi: 10.1007/s40620-020-00893-z.
10
Dutch nOcturnal and hoME dialysis Study To Improve Clinical Outcomes (DOMESTICO): rationale and design.荷兰夜间和家庭透析改善临床结局研究(DOMESTICO):原理与设计。
BMC Nephrol. 2019 Sep 18;20(1):361. doi: 10.1186/s12882-019-1526-4.

引用本文的文献

1
Transportable, portable, wearable and (partially) implantable haemodialysis systems: comparison of technologies and readiness levels.可运输、便携式、可穿戴及(部分)可植入式血液透析系统:技术与技术就绪水平比较
Clin Kidney J. 2024 Aug 24;17(9):sfae259. doi: 10.1093/ckj/sfae259. eCollection 2024 Sep.
2
Impact of mobile application and outpatient follow-up on renal endpoints and physiological indices in patients with chronic kidney disease: a retrospective cohort study in Southwest China.移动应用程序和门诊随访对慢性肾脏病患者肾脏终点事件和生理指标的影响:中国西南地区的一项回顾性队列研究
BMC Med Inform Decis Mak. 2024 Jun 12;24(1):163. doi: 10.1186/s12911-024-02567-3.
3
Digital Health Support: Current Status and Future Development for Enhancing Dialysis Patient Care and Empowering Patients.数字健康支持:提高透析患者护理水平和赋能患者的现状和未来发展。
Toxins (Basel). 2024 Apr 30;16(5):211. doi: 10.3390/toxins16050211.
4
Supporting patient self-management: A cross-sectional and prospective cohort study investigating Patient Activation Measure (PAM) and Clinician Support for PAM scores as part of a multi-centre haemodialysis breakthrough series collaborative.支持患者自我管理:一项横断面和前瞻性队列研究,调查患者激活量表(PAM)和临床医生对 PAM 评分的支持,作为多中心血液透析突破系列协作的一部分。
PLoS One. 2024 May 22;19(5):e0303299. doi: 10.1371/journal.pone.0303299. eCollection 2024.
5
Peritoneal Dialysis Technique Survival: A Cohort Study.腹膜透析技术生存率:一项队列研究。
Am J Kidney Dis. 2024 Sep;84(3):298-305.e1. doi: 10.1053/j.ajkd.2024.03.012. Epub 2024 Apr 17.
6
Impact of the COVID-19 pandemic on services for patients with chronic kidney disease: findings of a national survey of UK kidney centres.COVID-19 大流行对慢性肾脏病患者服务的影响:英国肾脏中心全国调查的结果。
BMC Nephrol. 2023 Dec 4;24(1):356. doi: 10.1186/s12882-023-03344-6.
7
Risk of COVID-19 and Cost Burden in End-Stage Renal Disease Patients and Policy Implications for Managing Nephrology Services during the COVID-19 Pandemic.终末期肾病患者感染新冠病毒的风险及成本负担,以及新冠疫情期间肾脏病服务管理的政策启示
Healthcare (Basel). 2022 Nov 23;10(12):2351. doi: 10.3390/healthcare10122351.
8
Application of Telemedicine in COVID-19: A Bibliometric Analysis.远程医疗在 COVID-19 中的应用:文献计量分析。
Front Public Health. 2022 May 26;10:908756. doi: 10.3389/fpubh.2022.908756. eCollection 2022.
9
Peritoneal dialysis first policy in Hong Kong for 35 years: Global impact.腹膜透析优先政策在香港实施 35 年:全球影响。
Nephrology (Carlton). 2022 Oct;27(10):787-794. doi: 10.1111/nep.14042. Epub 2022 Apr 13.
10
Kidney Care during COVID-19 in the UK: Perspectives of Healthcare Professionals on Impacts on Care Quality and Staff Well-Being.英国 COVID-19 期间的肾脏护理:医疗保健专业人员对护理质量和员工福祉影响的看法。
Int J Environ Res Public Health. 2021 Dec 24;19(1):188. doi: 10.3390/ijerph19010188.

本文引用的文献

1
Remote Patient Management in Peritoneal Dialysis: Opportunities and Challenges.腹膜透析中的远程患者管理:机遇与挑战。
Contrib Nephrol. 2019;197:54-64. doi: 10.1159/000496309. Epub 2019 Apr 8.
2
Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients.法国透析患者全国队列中的 SARS-CoV-2 发病率低、死亡风险因素和疾病过程。
Kidney Int. 2020 Dec;98(6):1519-1529. doi: 10.1016/j.kint.2020.07.042. Epub 2020 Aug 25.
3
Remote patient monitoring in peritoneal dialysis helps reduce risk of hospitalization during Covid-19 pandemic.腹膜透析中的远程患者监测有助于降低新冠疫情期间的住院风险。
J Nephrol. 2020 Dec;33(6):1123-1124. doi: 10.1007/s40620-020-00822-0.
4
The advantages of peritoneal dialysis over hemodialysis during the COVID-19 pandemic.在新冠疫情期间腹膜透析相对于血液透析的优势。
Semin Dial. 2020 Sep;33(5):369-371. doi: 10.1111/sdi.12903. Epub 2020 Jul 16.
5
COVID-19 Outbreak in a Large Hemodialysis Center in Lombardy, Italy.意大利伦巴第大区一家大型血液透析中心的新冠疫情。
Kidney Int Rep. 2020 May 24;5(7):1095-1099. doi: 10.1016/j.ekir.2020.05.019. eCollection 2020 Jul.
6
Exposure to novel coronavirus in patients on renal replacement therapy during the exponential phase of COVID-19 pandemic: survey of the Italian Society of Nephrology.COVID-19 大流行指数增长阶段接受肾脏替代治疗的患者中新型冠状病毒暴露情况:意大利肾脏病学会调查。
J Nephrol. 2020 Aug;33(4):725-736. doi: 10.1007/s40620-020-00794-1. Epub 2020 Jul 3.
7
COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis.新型冠状病毒肺炎、低分子量肝素与血液透析
Kidney Blood Press Res. 2020;45(3):357-362. doi: 10.1159/000508460. Epub 2020 May 25.
8
Clinical Characteristics of and Medical Interventions for COVID-19 in Hemodialysis Patients in Wuhan, China.中国武汉血液透析患者 COVID-19 的临床特征和医学干预措施。
J Am Soc Nephrol. 2020 Jul;31(7):1387-1397. doi: 10.1681/ASN.2020030354. Epub 2020 May 8.
9
Peritoneal Dialysis in the time of COVID-19.新冠疫情期间的腹膜透析
Perit Dial Int. 2020 Jul;40(4):357-358. doi: 10.1177/0896860820921657. Epub 2020 Apr 21.
10
Kidney disease is associated with in-hospital death of patients with COVID-19.肾病与 COVID-19 患者住院期间的死亡相关。
Kidney Int. 2020 May;97(5):829-838. doi: 10.1016/j.kint.2020.03.005. Epub 2020 Mar 20.